InspireMD- Warrants Return on Equity

InspireMD- Warrants (NSPRZ) currently reports a ROE of -67.62%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore InspireMD- Warrants's ROE history and peer comparisons.

InspireMD- Warrants's ROE of -67.62% is lower than the Healthcare sector average of 29.33%. That is roughly 330.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but InspireMD- Warrants's current -67.62% should be judged against Healthcare norms (sector average: 29.33%) and against NSPRZ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -67.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for InspireMD- Warrants, and consider following NSPRZ for alerts when major investors trade the stock.

InspireMD- Warrants is classified in the Healthcare sector. On ROE, it currently shows -67.62% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NSPRZ with unrelated industries.